142 related articles for article (PubMed ID: 2653501)
21. Deferoxamine as a purging agent for autologous bone marrow grafts in neuroblastoma.
Skala JP; Rogers PC; Chan KW; Chao HY; Rodriguez WC
Prog Clin Biol Res; 1992; 377():71-8. PubMed ID: 1438447
[No Abstract] [Full Text] [Related]
22. Properties of antileukaemic drugs.
Brusamolino E
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():30-3. PubMed ID: 2653515
[No Abstract] [Full Text] [Related]
23. Merocyanine 540-sensitized photoinactivation of leukemia cells: role of oxygen and effects on plasma membrane integrity and mitochondrial respiration.
Gaffney DK; Schober SL; Sieber F
Exp Hematol; 1990 Jan; 18(1):23-6. PubMed ID: 2298265
[TBL] [Abstract][Full Text] [Related]
24. Susceptibility to merocyanine 540-mediated photosensitization as a differentiation marker in murine hematopoietic stem cells.
Sieber F; Meagher RC; Spivak JL
Prog Clin Biol Res; 1982; 85 Pt B():135-44. PubMed ID: 7122563
[No Abstract] [Full Text] [Related]
25. Drug-mediated marrow purging: mafosfamide in adult acute leukemia in remission. The experience of the Italian study group.
Rizzoli U; Mangoni L; Carella AM; Aglietta M; Porcellini A; Coleselli P; Angrilli F; Alessandrino EP; Madon E; Locatelli F
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():190-4. PubMed ID: 2653502
[No Abstract] [Full Text] [Related]
26. Importance of cellular defense mechanisms in the photodynamic purging of autologous bone marrow grafts.
Sieber F; Gaffney DK; Yamazaki T; Qiu K
Prog Clin Biol Res; 1994; 389():147-54. PubMed ID: 7700897
[No Abstract] [Full Text] [Related]
27. Effect of cryopreservation on purging of leukemic marrow with alkyl-lysophospholipids.
Vogler WR; Somberg LB; Glasser L
Exp Hematol; 1987 May; 15(4):360-4. PubMed ID: 3569439
[TBL] [Abstract][Full Text] [Related]
28. Merocyanine 540-sensitized photoinactivation of high-grade non-Hodgkin's lymphoma cells: potential application in autologous BMT.
Itoh T; Messner HA; Jamal N; Tweeddale M; Sieber F
Bone Marrow Transplant; 1993 Sep; 12(3):191-6. PubMed ID: 8241975
[TBL] [Abstract][Full Text] [Related]
29. Bone marrow purging with antisense oligodeoxynucleotides.
Gewirtz AM
Prog Clin Biol Res; 1992; 377():215-24; discussion 225-6. PubMed ID: 1438418
[No Abstract] [Full Text] [Related]
30. Differential phthalocyanine photosensitization of acute myeloblastic leukaemia progenitor cells: a potential purging technique for autologous bone marrow transplantation.
Singer CR; Linch DC; Bown SG; Huehns ER; Goldstone AH
Br J Haematol; 1988 Apr; 68(4):417-22. PubMed ID: 3288271
[TBL] [Abstract][Full Text] [Related]
31. Mixed chimerism after allogeneic marrow transplantation.
Frassoni F; Corvo R; Strada P; Sessarego M; Piaggio G; Figari O; Scarpati D; Bacigalupo A; Vitale V; Miceli S
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():241-3. PubMed ID: 2653512
[No Abstract] [Full Text] [Related]
32. Efficacy of benzoporphyrin derivative, a photosensitizer, in selective destruction of leukemia cells using a murine tumor model.
Jamieson C; Richter A; Levy JG
Exp Hematol; 1993 May; 21(5):629-34. PubMed ID: 8513863
[TBL] [Abstract][Full Text] [Related]
33. [Experimental and clinical use of cell cultures in chronic myeloid leukemia].
Burgaleta C; Soria H; Moreno T
Sangre (Barc); 1984; 29(4-B):549-64. PubMed ID: 6393382
[No Abstract] [Full Text] [Related]
34. The effects of acetaldophosphamide, a novel stable aldophosphamide analogue, on normal human and leukemic progenitor cells in vitro: implications for use in bone marrow purging.
Beran M; Andersson BS; Wang Y; McCredie KB; Farquhar D
Cancer Res; 1988 Jan; 48(2):339-45. PubMed ID: 3275495
[TBL] [Abstract][Full Text] [Related]
35. Photodynamic elimination of clonogenic Ph+ chronic myeloid leukemia cells.
Keating A; Jamieson C; Hornby A; Wang XH; Levy J
Leuk Lymphoma; 1993; 11 Suppl 1():265-9. PubMed ID: 8251908
[TBL] [Abstract][Full Text] [Related]
36. Comparison of colony-stimulating activities for evaluating in vitro granulomonopoiesis in normal subjects and in patients with myeloid leukemias.
López-Karpovitch X; Padrós-Semorile MR; Hurtado-Monroy R; Cárdenas MR; Niesvizky N; Martínez-Sánchez L; Rojas R
Rev Invest Clin; 1985; 37(4):323-7. PubMed ID: 3879370
[No Abstract] [Full Text] [Related]
37. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
Gidáli J; Fehér I; Kovács P
Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126
[TBL] [Abstract][Full Text] [Related]
38. Induction of tumor cell differentiation as a therapeutic approach: preclinical models for hematopoietic and solid neoplasms.
Reiss M; Gamba-Vitalo C; Sartorelli AC
Cancer Treat Rep; 1986 Jan; 70(1):201-18. PubMed ID: 3510735
[No Abstract] [Full Text] [Related]
39. [Radiosensitizing action of 8-bromoadenine on hematopoietic stem cells in mouse bone marrow].
Volchkov VA; Vartanian LP; Mikhaĭlova NIa
Radiobiologiia; 1982; 22(1):117-9. PubMed ID: 7063645
[No Abstract] [Full Text] [Related]
40. Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage.
Wierenga PK; Konings AW
Exp Hematol; 1996 Feb; 24(2):246-52. PubMed ID: 8641348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
